Joint United Nations Programme on HIV/AIDS. HIV and adolescent girls and young women — Thematic briefing note — 2024 global AIDS update The Urgency of Now: AIDS at a Crossroads. 2024; Available from: https://www.unaids.org/sites/default/files/media_asset/2024-unaids-global-aids-update-adolescent-girls-young-women_en.pdf. Cited 2025 Apr 19.
Girum T, Wasie A, Lentiro K, Muktar E, Shumbej T, Difer M et al. Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Archives of Public Health . 2018;76(1):1–10. Available from: Cited 2025 Jan 3.
Addo MM, Altfeld M. Sex-Based Differences in HIV Type 1 Pathogenesis. J Infect Dis . 2014;209(Suppl 3):S86-92. Available from: https://pmc.ncbi.nlm.nih.gov/articles/pmid/24966195/. Cited 2025 Jan 3.
Magadi MA. Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys. Sociol Health Illn. 2011;33(4):522–39. Available from: Cited 2025 Jan 3
Colvin CJ, Konopka S, Chalker JC, Jonas E, Albertini J, Amzel A et al. A Systematic Review of Health System Barriers and Enablers for Antiretroviral Therapy (ART) for HIV-Infected Pregnant and Postpartum Women. PLoS One. 2014;9(10):e108150. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4193745/. Cited 2025 Apr 22.
Joseph Davey DL, Bekker LG, Gorbach PM, Coates TJ, Myer L. Delivering PrEP to pregnant and breastfeeding women in sub-Saharan Africa: The Implementation Science Frontier. AIDS. 2017;31(16):2193. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5633500/. Cited 2024 Oct 21.
Moran A, Mashele N, Mvududu R, Gorbach P, Bekker LG, Coates TJ et al. Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence. AIDS Behav. 2022;26(1):205–17. Available from: Cited 2024 Aug 21.
Beesham I, Dovel K, Mashele N, Bekker LG, Gorbach P, Coates TJ et al. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa. AIDS Behav. 2022;26(9):3079–87. Available from: https://pubmed.ncbi.nlm.nih.gov/35316471/. Cited 2023 Jun 23.
Nelson A, Bheemraj K, Dean SS, de Voux A, Hlatshwayo L, Mvududu R et al. Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study. BMC Global and Public Health. 2024;2(1):1–14. Available from: Cited 2025 Apr 19.
Chen-Charles J, Joseph Davey D, Toska E, Seeley J, Bekker LG. PrEP Uptake and Utilisation Among Adolescent Girls and Young Women in Sub-Saharan Africa: A Scoping Review. AIDS and Behavior 2025. 2025;1–21. Available from: article/ Cited 2025 Mar 27.
Rousseau E, Sikkema KJ, Julies RF, Mazer K, O’Malley G, Heffron R et al. Exploring adolescent girls and young women’s PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa. J Int AIDS Soc. 2024;27(5):e26254. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11063778/. Cited 2025 Apr 19.
Groves AK, Maman S, Stankard PH, Gebrekristos LT, Amon JJ, Moodley D. Addressing the unique needs of adolescent mothers in the fight against HIV. J Int AIDS Soc. 2018;21(6):e25155. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6024120/. Cited 2024 Dec 9.
Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P et al. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. Int J STD AIDS. 2023;34(8):548–56. Available from: https://pubmed.ncbi.nlm.nih.gov/36947792/. Cited 2025 Apr 21.
Admassu M, Nöstlinger C, Hensen B. Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review. BMC Womens Health. 2024;24(1). Available from: https://pubmed.ncbi.nlm.nih.gov/39725977/. Cited 2025 Apr 21.
Rogers Z, Pintye J, Kinuthia J, O’Malley G, Abuna F, Escudero J et al. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya. AIDS Care. 2021;34(3):363. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8934309/. Cited 2025 Apr 21.
Khadka N, Gorbach PM, Nyemba DC, Mvududu R, Mashele N, Javanbakht M et al. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa. Frontiers in Reproductive Health. 2023;5. Available from: https://www.pmc/articles/PMC10546059/. Cited 2023 Oct 19.
Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res . 2021;21(1):1–10. Available from: Cited 2023 Aug 18.
Rousseau E, Joseph Davey D, Fynn L, Wallace M, Macdonald P, Pike C et al. FastPrEP: A protocol to evaluate uptake, coverage, and effectiveness of a youth-focused, decentralised and differentiated district-wide HIV pre-exposure prophylaxis program. 2024; Available from: https://www.researchsquare.com. Cited 2024 Dec 19.
National Department of Health South Africa. Updated Guidelines for the Provision of Oral Pre-Exposure Prophylaxis (PrEP) to Persons at Substantial Risk of HIV Infection 2021. 2021. Available from: https://knowledgehub.health.gov.za/system/files/elibdownloads/2023-04/PrEP%2520Guidelines%2520Update%252012%2520%2520Nov%2520%25202021%2520Final.pdf. Cited 2024 Sep 17.
Joseph Davey DL, Mvududu R, Mashele N, Bheemraj K, Khadka N, Johnson LF et al. Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study. Lancet HIV. 2024;11(11):e746–55. Available from: https://doi.org/10.1016/S2352-3018(24)00240-6
Rousseau E, Davey DJ, Fynn LS, Wallace M, Macdonald P, Pike C et al. FastPrEP: a protocol to evaluate uptake, coverage, and effectiveness of a youth-focused, decentralised and differentiated district-wide HIV pre-exposure prophylaxis program. BMC Public Health. 2025;25(1). Available from: https://pubmed.ncbi.nlm.nih.gov/41174517/. Cited 2025 Dec 14.
Chen-Charles J, Vundhla P, Coakley C, Toska E, Rousseau E, Bekker LG. Dream PrEP delivery package: Co-Creating innovative PrEP delivery with pregnant or parenting young women in South Africa. AIDS Care. 2025.
Ngure K, Thuo N, Ogello V, Kiptinness C, Kamolloh K, Burns BFOR et al. Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study. Frontiers in Reproductive Health. 2021 ;3:637869. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9580724/. Cited 2025 Apr 22.
Atkins K, Rucinski K, Mudavanhu M, Holmes L, Mutunga L, Kaufman MR et al. Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis. J Acquir Immune Defic Syndr. 2021;86(4):413–21. Available from: https://pubmed.ncbi.nlm.nih.gov/33196552/. Cited 2025 Apr 22.
Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D et al. Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa. Frontiers in Reproductive Health. 2023 ;5:1073103. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10266091/. Cited 2025 Apr 22.
Holmes LE, Kaufman MR, Casella A, Mudavanhu M, Mutunga L, Polzer T et al. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades. J Int AIDS Soc. 2020;23 Suppl 3(Suppl 3). Available from: https://pubmed.ncbi.nlm.nih.gov/32603025/. Cited 2025 Apr 22.
de Voux A, Nyemba DC, Silliman M, Mashele N, Mvududu R, Myer L et al. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021–2022: randomised controlled trial. Sex Transm Infect. 2023;100(2):77–83. Available from: https://pubmed.ncbi.nlm.nih.gov/38124133/. Cited 2025 Jun 13.
Davey DLJ, Dovel K, Mvududu R, Nyemba D, Mashele N, Bekker LG et al. Pre-exposure Prophylaxis Recent Adherence with Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial among Postpartum Women. Open Forum Infect Dis. 2022;9(2). Available from: https://pubmed.ncbi.nlm.nih.gov/35097151/. Cited 2025 Jun 13.
Joseph Davey D, Fynn L, Rousseau E, Macdonald P, Leonard B, Lebelo K et al. Evaluation of point-of-care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study. J Int AIDS Soc. 2025;28(5). Available from: https://pubmed.ncbi.nlm.nih.gov/40356266/. Cited 2025 Jun 13.
Ekwunife OI, Ejie IL, Okelu V, Mita C, Durosinmi-Eti O, Powell A et al. Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review. BMJ Glob Health. 2022;7(12):e009474. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9743293/. Cited 2025 Jun 13.
Chu ZX, Jin X, Ye ZH, Zhu YY, Huang XJ, Wang H et al. Real-time digital intervention on oral pre-exposure prophylaxis adherence among MSM: randomized controlled trial. NPJ Digit Med. 2025;8(1):1–8. Available from: https://pmc.ncbi.nlm.nih.gov/articles/pmid/40500334/. Cited 2025 Jun 13.
Nakalega R, Mukiza N, Menge R, Kizito S, Babirye JA, Kuteesa CN et al. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda. BMC Public Health. 2023;23(1):1–12. Available from: Cited 2025 Jun 13.
Fernandez C, van Halsema CL. Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: Emerging data and therapeutic potential. HIV AIDS (Auckl). 2019;11(eCollection 2019):179–92. Available from: https://pmc.ncbi.nlm.nih.gov/articles/pmid/31447590/. Cited 2020 Jul 16.
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W et al. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. New England Journal of Medicine. 2024;391:1179–92. Available from: Cited 2024 Oct 21.
de Vos L, Mussa A, Rousseau E, Strauss M, George G, Vundhla P et al. Preference for Service Delivery for Long-Acting Pre-exposure Prophylaxis for HIV Infection Among Pregnant and Breastfeeding Women in South Africa and Botswana. AIDS Behav. 2025;1–13. Available from: Cited 2025 Jun 13.
Chen-Charles J, De Vos L, Vundhla P, Gebengu A, Rousseau E, Bekker LG et al. Empowering Women’s PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana. AIDS and Behavior 2025. 2025;1–16. Available from: Cited 2025 Sep 17.
date: 2026-02-09 02:47:00